The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Year to date metric has recorded a loss of -90.68%.However, over the last six months, we can see a stronger performance of -90.83%. Over the last 30 days, the price of CTOR has leaped by -13.92%. And in the last five days, it has surged by 19.70%.
Citius Oncology Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $49.00 on 08/06/24, with the lowest value being $0.85 on 11/26/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of CTOR Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Citius Oncology Inc’s current trading price is -97.92% away from its 52-week high, while its distance from the 52-week low is 20.00%. The stock’s price range over this timeframe has been between $0.85 and $49.00. The shares of the Healthcare sector company recorded a trading volume of approximately 4.31 million for the day, which was comparatively higher than the average daily volume of 0.13 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Citius Oncology Inc (CTOR) has experienced a quarterly decline of -40.00% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 71.10M.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 4.4181, with a change in price of -10.3300. Similarly, Citius Oncology Inc recorded 235,849 in trading volume during the last 100 days, posting a change of -91.01%.
CTOR’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for CTOR stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.00.
CTOR Stock Stochastic Average
The raw stochastic average for Citius Oncology Inc over the last 50 days is presently at 16.04%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 28.52%. Further, the company’s Stochastic %K and %D values for the last 20 days were 18.41% and 16.87%, respectively.
